|
CIPROFLOXACIN Injection, USP
|
|
|
|
|
| Brand Name Equivalent: CIPRO® (CIPRO is a registered trademark of Bayer Aktiengesellschaft Joint Stock Company)
|
Electronic Catalog
|
Therapeutic Category: Anti-infective / Antibiotic
|
- Consider these SAGENT benefits:
- • Available in:
• 200 mg premix bags
• 400 mg premix bags
• Enhanced packaging
• Ready-to-use convenience
• Bar coding
• LATEX-FREE
|
|
|
|
| 360o View |
| 114-82
|
Premix Bag
|
200 mg
|
100 mL
|
2 mg per mL
|
N/A
|
N/A |
24 |
 |

|
 |
 |
| 114-87
|
Premix Bag
|
400 mg
|
200 mL
|
2 mg per mL
|
N/A
|
N/A
|
24
|
 |

|
 |
 |
|
WARNING:
Fluoroquinolones, including CIPROFLOXACIN Injection, USP, are associated with an increased risk of tendinitis and tendon rupture in all ages. This risk is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants (see WARNINGS).
Fluoroquinolones, including CIPROFLOXACIN Injection, USP, may exacerbate muscle weakness in persons with myasthenia gravis. Avoid CIPROFLOXACIN Injection, USP in patients with known history of myasthenia gravis (see WARNINGS).
|
Please refer to full prescribing information and medication guide.
[Back to Products page] |
LATEX-FREE = There is no natural rubber latex in the bag material or port(s) in this SAGENT product.
This product information is intended for U.S. residents only. All trademarks and registered
trademarks are the property of their respective owners.
|
|